Published 22 days ago • loading... • Updated 22 days agoShow Less IconAlcon Sees Another Bullish Rating After Clear Portfolio Growth Direction In Eyecare (ALC) Summary by Seeking AlphaAlcon Inc. remains a Buy, supported by FDA approvals, portfolio-expanding acquisitions, and robust long-term eyecare demand. Click for more details on ALC.Share menu1 Articles1 ArticlesAllLeftCenterRight1Search IconSort IconSeeking AlphaLean RightFactualityOwnershipAlcon Sees Another Bullish Rating After Clear Portfolio Growth Direction In Eyecare (ALC)Alcon Inc. remains a Buy, supported by FDA approvals, portfolio-expanding acquisitions, and robust long-term eyecare demand. Click for more details on ALC.22 days ago·Ra'anana, IsraelRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right1Center0Last Updated22 days agoBias Distribution100% RightBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources lean Right100% RightR 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageSeeking Alpha broke the news in Ra'anana, Israel 22 days ago on Wednesday, October 21, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsGeneva, Switzerland Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsGeneva, Switzerland Plus IconShow All